Publications by authors named "Markus Neef"

Claim this Profile
C
Corrigendum to "Dissecting the genetic heterogeneity of gastric cancer".
Timo Hess, Carlo Maj, Jan Gehlen, Oleg Borisov, Stephan L Haas, Markus Neef

EBioMedicine· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissecting the genetic heterogeneity of gastric cancer.
Timo Hess, Carlo Maj, Jan Gehlen, Oleg Borisov, Stephan L Haas, Markus Neef

EBioMedicine· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
Frank Grünhage, Bettina Rezori, Markus Neef, Frank Lammert, Tilman Sauerbruch

Clin Gastroenterol Hepatol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis.
Markus Neef, Monika Ledermann, Hans Saegesser, Vreni Schneider, Juerg Reichen

J Hepatol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term.
Markus Neef, Monika Ledermann, Hans Saegesser, Vreni Schneider, Nicolas Widmer

J Hepatol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms.
Erwin Biecker, Andrea De Gottardi, Markus Neef, Matthias Unternährer, Vreni Schneider

J Pharmacol Exp Ther· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular, hemodynamic and renal effects of low-dose losartan in rats with secondary biliary cirrhosis.
Jörg Heller, Jonel Trebicka, Thomas Shiozawa, Michael Schepke, Markus Neef

Liver Int· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide synthase 1 is partly compensating for nitric oxide synthase 3 deficiency in nitric oxide synthase 3 knock-out mice and is elevated in murine and human cirrhosis.
Erwin Biecker, Markus Neef, Hans Sägesser, Sidney Shaw, Abraham Koshy

Liver Int· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acenocoumarol is not a safe alternative for anticoagulation in phenprocoumon-induced hepatic failure. Report of two cases.
Markus Neef, Zsuzsanna Kerekes, Hans-Peter Fischer, Tilman Sauerbruch, Ulrich Spengler

Digestion· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased urotensin II plasma levels in patients with cirrhosis and portal hypertension.
Jörg Heller, Michael Schepke, Markus Neef, Rainer Woitas, Christian Rabe

J Hepatol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis